G1 Therapeutics, Inc. (GTHX) Tops Q4 EPS by 8c

G1 Therapeutics, Inc. (NASDAQ: GTHX) reported Q4 EPS of ($0.73), $0.08 better than the analyst estimate of ($0.81). Revenue for the quarter came in at $10.25 million versus the consensus estimate of $9.84 million.

For earnings history and earnings-related data on G1 Therapeutics, Inc. (GTHX) click here.

You May Also Be Interested In

• Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
• Helix and Hornbeck complete all-stock merger, form new NYSE: HOS
• Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance